Transcriptional Regulation of the TATA-binding Protein by Ras Cellular Signaling
Overview
Authors
Affiliations
Our previous studies have demonstrated that the level of the central transcription factor TATA-binding protein (TBP) is increased in cells expressing the hepatitis B virus (HBV) X protein through the activation of the Ras signaling pathway, which serves to enhance both RNA polymerase I and III promoter activities. To understand the mechanism by which TBP is regulated, we have investigated whether enhanced expression is modulated at the transcriptional level. Nuclear run-on assays revealed that the HBV X protein increases the number of active transcription complexes on the TBP gene. In transient-transfection assays with both transformed and primary hepatocytes, the human TBP promoter was shown to be induced by expression of the HBV X protein in a Ras-dependent manner, requiring both Ral guanine nucleotide dissociation stimulator (RalGDS) and Raf signaling. Transient overexpression of TBP did not affect TBP promoter activity. To further delineate the downstream Ras-mediated events contributing to TBP promoter regulation in primary rat hepatocytes, the best-characterized Ras effectors, Raf, phosphoinositide 3-kinase (PI-3 kinase), and RalGDS, were examined. Activation of either Raf or RalGDS, but not that of PI-3 kinase, was sufficient to induce TBP promoter activity. Both Raf- and RalGDS-mediated induction required the activation of mitogen-activated protein kinase kinase (MEK). In addition, another distinct Ras-activated pathway, which does not require MEK activation, appears to induce TBP promoter activity. Analysis of the DNA sequence requirement within the TBP promoter responsible for these regulatory events defined three distinct regions that modulate the abilities of Raf, RalGDS, and the Ras-dependent, MEK-independent pathways to regulate human TBP promoter activity. Together, these results provide new evidence that TBP can be regulated at the transcriptional level and identify three distinct Ras-activated pathways that modulate this central eukaryotic transcription factor.
The transcription factor TBP promotes hepatocellular carcinoma progression by activating AKT3.
Jiang F, Lin Y, Du J, Qiu S, Luo G, Zhang Z Am J Cancer Res. 2023; 13(11):5656-5666.
PMID: 38058816 PMC: 10695801.
Widespread association of ERα with RMRP and tRNA genes in MCF-7 cells and breast cancers.
Malcolm J, Leese N, Lamond-Warner P, Brackenbury W, White R Gene. 2022; 821:146280.
PMID: 35143945 PMC: 8942118. DOI: 10.1016/j.gene.2022.146280.
Cellular Substrates for Cell-Based Tissue Engineering of Human Corneal Endothelial Cells.
Zhu Q, Sun H, Yang D, Tighe S, Liu Y, Zhu Y Int J Med Sci. 2019; 16(8):1072-1077.
PMID: 31523168 PMC: 6743271. DOI: 10.7150/ijms.34440.
Transcribing malignancy: transcription-associated genomic instability in cancer.
Boulianne B, Feldhahn N Oncogene. 2017; 37(8):971-981.
PMID: 29106394 DOI: 10.1038/onc.2017.402.
Johnson S, Lin J, Walkey C, Leathers M, Coarfa C, Johnson D Oncotarget. 2017; 8(30):48832-48845.
PMID: 28415573 PMC: 5564728. DOI: 10.18632/oncotarget.16384.